183 related articles for article (PubMed ID: 36815024)
1. Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats.
Koizumi T; Watanabe M; Yokota T; Tsuda M; Handa H; Koya J; Nishino K; Tatsuta D; Natsui H; Kadosaka T; Koya T; Nakao M; Hagiwara H; Kamada R; Temma T; Tanaka S; Anzai T
Front Cardiovasc Med; 2023; 10():1005408. PubMed ID: 36815024
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
[TBL] [Abstract][Full Text] [Related]
3. Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress.
Bugga P; Mohammed SA; Alam MJ; Katare P; Meghwani H; Maulik SK; Arava S; Banerjee SK
Life Sci; 2022 Oct; 307():120862. PubMed ID: 35934058
[TBL] [Abstract][Full Text] [Related]
4. Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats.
Gong M; Yuan M; Meng L; Zhang Z; Tse G; Zhao Y; Zhang Y; Yuan M; Liang X; Fan G; Yan GX; Li G; Liu T
Oxid Med Cell Longev; 2020; 2020():2468031. PubMed ID: 32104528
[TBL] [Abstract][Full Text] [Related]
5. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.
Saito S; Teshima Y; Fukui A; Kondo H; Nishio S; Nakagawa M; Saikawa T; Takahashi N
Cardiovasc Res; 2014 Oct; 104(1):5-14. PubMed ID: 25082849
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats.
Lee TI; Chen YC; Lin YK; Chung CC; Lu YY; Kao YH; Chen YJ
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987285
[TBL] [Abstract][Full Text] [Related]
7. Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
Yurista SR; Silljé HHW; Rienstra M; de Boer RA; Westenbrink BD
Cardiovasc Diabetol; 2020 Jan; 19(1):5. PubMed ID: 31910841
[TBL] [Abstract][Full Text] [Related]
8. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.
Steven S; Oelze M; Hanf A; Kröller-Schön S; Kashani F; Roohani S; Welschof P; Kopp M; Gödtel-Armbrust U; Xia N; Li H; Schulz E; Lackner KJ; Wojnowski L; Bottari SP; Wenzel P; Mayoux E; Münzel T; Daiber A
Redox Biol; 2017 Oct; 13():370-385. PubMed ID: 28667906
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy.
Lee YH; Kim SH; Kang JM; Heo JH; Kim DJ; Park SH; Sung M; Kim J; Oh J; Yang DH; Lee SH; Lee SY
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F767-F780. PubMed ID: 31390268
[TBL] [Abstract][Full Text] [Related]
10. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
[TBL] [Abstract][Full Text] [Related]
11. Impact of empagliflozin on left atrial mechanical and conduction functions in patients with type 2 diabetes mellitus.
Aslan M; Oksen D; Kaynak C; Ozudogru O
J Clin Ultrasound; 2023 Mar; 51(3):398-404. PubMed ID: 36308321
[TBL] [Abstract][Full Text] [Related]
12. Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits.
Zhang X; Zhang Z; Zhao Y; Jiang N; Qiu J; Yang Y; Li J; Liang X; Wang X; Tse G; Li G; Liu T
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28507060
[TBL] [Abstract][Full Text] [Related]
13. Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway.
Xue X; Ling X; Xi W; Wang P; Sun J; Yang Q; Xiao J
Mol Med Rep; 2020 Sep; 22(3):1759-1766. PubMed ID: 32705232
[TBL] [Abstract][Full Text] [Related]
14. Melatonin ameliorates diabetic hyperglycaemia-induced impairment of Leydig cell steroidogenic function through activation of SIRT1 pathway.
Wang P; Zhang S; Lin S; Lv Z
Reprod Biol Endocrinol; 2022 Aug; 20(1):117. PubMed ID: 35962432
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
Li C; Zhang J; Xue M; Li X; Han F; Liu X; Xu L; Lu Y; Cheng Y; Li T; Yu X; Sun B; Chen L
Cardiovasc Diabetol; 2019 Feb; 18(1):15. PubMed ID: 30710997
[TBL] [Abstract][Full Text] [Related]
16. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin ameliorates symptoms of diabetes and renal tubular dysfunction in a rat model of diabetes with enlarged kidney (DEK).
Domon A; Katayama K; Sato T; Tochigi Y; Tazaki H; Suzuki H
PLoS One; 2021; 16(5):e0251135. PubMed ID: 33945582
[TBL] [Abstract][Full Text] [Related]
18. Activation of NADPH oxidase mediates mitochondrial oxidative stress and atrial remodeling in diabetic rabbits.
Zhou L; Liu Y; Wang Z; Liu D; Xie B; Zhang Y; Yuan M; Tse G; Li G; Xu G; Liu T
Life Sci; 2021 May; 272():119240. PubMed ID: 33600862
[TBL] [Abstract][Full Text] [Related]
19. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation.
Koyani CN; Plastira I; Sourij H; Hallström S; Schmidt A; Rainer PP; Bugger H; Frank S; Malle E; von Lewinski D
Pharmacol Res; 2020 Aug; 158():104870. PubMed ID: 32434052
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes.
Xu L; Xu C; Liu X; Li X; Li T; Yu X; Xue M; Yang J; Kosmas CE; Moris D; Sanchis-Gomar F; Yoshida N; Berger NA; Aronow WS; Sun B; Chen L
Front Physiol; 2021; 12():745058. PubMed ID: 34777009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
